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Abstract  34 
Domestic wastewater is a recognized source of antibiotic resistant bacteria and antibiotic 35 
resistance genes (ARB&ARGs), whose risk of transmission to humans cannot be ignored. 36 
The fitness of wastewater ARB in the complex fecal microbiota of a healthy human was 37 
investigated in feces-based microcosm assays (FMAs). FMAs were inoculated with two 38 
wastewater isolates, Escherichia coli strain A2FCC14 (MLST ST131) and Enterococcus 39 
faecium strain H1EV10 (MLST ST78), harboring the ARGs blaTEM, blaCTX, blaOXA-A and 40 
vanA, respectively. The FMAs, incubated in the presence or absence of oxygen or in the 41 
presence or absence of the antibiotics cefotaxime or vancomycin, were monitored based 42 
on cultivation, ARGs quantification and bacterial community analysis.  43 
The fecal bacterial community was dominated by members of the phyla Firmicutes, 44 
Bacteroidetes, Actinobacteria, Proteobacteria and Verrucomicrobia. The ARGs 45 
harbored by the wastewater isolates could be quantified after one week, in FMAs 46 
incubated under both aerobic and anaerobic conditions. These observations were not 47 
significantly different in FMAs incubated anaerobically, supplemented with sub-48 
inhibitory concentrations of cefotaxime or vancomycin. The observation that ARGs of 49 
wastewater ARB persisted in presence of the human fecal microbiota for at least one week 50 
supports the hypothesis of a potential transmission to humans, a topic that deserves further 51 
investigation.  52 
 53 
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One sentence summary:  58 
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Antibiotic resistance genes harbored by wastewater bacterial isolates persisted in healthy 59 
infant´s stool-based microcosms under different conditions, including the presence of 60 
sub-inhibitory concentrations of antibiotics. 61 
 62 
1. Introduction 63 
Antibiotic resistance, defined as the capability of bacteria to survive and proliferate in the 64 
presence of antibiotics, is a natural bacterial property (Davies and Davies 2010). Bacteria 65 
resistant to antibiotics, against which were once susceptible, owe that capability to the 66 
acquisition of antibiotic resistance genes (ARGs), most of the times through horizontal 67 
gene transfer (Bengtsson-Palme et al., 2018; Summers 2006). Acquired antibiotic 68 
resistance emergence and proliferation have been attributed to factors such as the 69 
presence of antibiotics and other antimicrobials, metals or conditions still unknown, 70 
which through their stressor effects exert what has been designated as selective pressures 71 
(Martinez 2008; Rosenblatt-Farrell 2009). Ubiquitous bacteria, harboring acquired 72 
antibiotic resistance genes, can thrive in the environment, in particular in wastewater, 73 
water, soil and wildlife (Berendonk et al., 2015; Huddleston 2014). The paths of 74 
transmission of these bacteria back to humans are not fully understood and the probability 75 
of such occurrence hardly can be estimated based on the current knowledge (Manaia 76 
2017). A still unanswered question refers to the capability of antibiotic resistant bacteria 77 
(ARB) from environmental origin, as well as their genes, to is survive or persist in the 78 
human body (Bengtsson-Palme et al., 2018; Larsson et al., 2018; Manaia 2017). 79 
Specifically, if it is assumed that the digestive tract is the entry portal, one of the questions 80 
would be if these bacteria would be able to survive the competition of complex intestinal 81 
microbiome (Manaia 2017; Vaz-Moreira et al., 2014). The role of the digestive tract as a 82 
relevant entry portal assumes a particular likeliness in situations of ingestion of raw 83 
vegetable-based food products, therefore acting as potential sources of ARB to humans 84 
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(Holzel et al., 2018; Valerio et al., 2006; Zhang et al., 2019). The risks of ARB occurrence 85 
in vegetables can be enhanced in scenarios of manure soil amendment or water reuse for 86 
irrigation (Becerra-Castro et al., 2015; Heuer et al., 2011; Marti et al., 2013). Indeed, 87 
several recent studies have shown the presence of ARB and ARGs in raw-eaten products 88 
(e.g. lettuce), raising concerns for consumers, particularly for immunocompromised 89 
people (Araujo et al., 2017; Blau et al., 2018; O'Flaherty et al., 2019; Zhang et al., 2017; 90 
Zhu et al., 2017). However, even after ingestion, the success of allochthonous bacteria in 91 
the intestinal tract is supposedly antagonized by the gut microbiota, a complex and 92 
dynamic community of microorganisms colonizing the gastrointestinal tract of humans 93 
since birth (Donaldson et al., 2016; Gibson et al., 2014). While indigenous (or 94 
autochthonous) microorganisms may have the intestine as a long term or almost 95 
permanent niche, allochthonous microorganisms may colonize transiently the human gut, 96 
although some, the most fitted, will be able to persist for long time periods (Milani et al., 97 
2017; Ventura et al., 2009). Among the most fitted bacterial groups, it can be 98 
hypothesized that bacteria of enteric origin, like Escherichia coli or Enterococcus spp., 99 
are good candidates to survive the competition of the fecal microbiome of a healthy 100 
individual. These can certainly be part of the 106 to 109 bacterial cells that, depending on 101 
the different dietary intake, can be ingested daily (Derrien and van Hylckama Vlieg 2015; 102 
Lang et al., 2014). If part of these bacteria carry acquired ARGs, such fact can 103 
hypothetically increase their fitness in the presence of antibiotics and/or facilitate the 104 
interchange of those genes with the native community (Salyers et al., 2004). Therefore, 105 
the contamination of the human food chain with environmental ARB might represent a 106 
risk for the subsequent transmission to humans. Among the multiple bottlenecks that may 107 
hamper the successful human-gut colonization by allochthonous bacteria, are the capacity 108 
to survive the complex native microbiome and/or the stability of the respective ARGs. 109 
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These questions boosted this study that used the fecal material of a healthy infant as a 110 
model of human gut microbiota to assess the persistence of enteric ARB isolated from 111 
wastewater, Escherichia coli strain A2FCC14 and Enterococcus faecium strain H1EV10, 112 
harboring the ARGs blaTEM, blaCTX-M, blaOXA-A and vanA, respectively. Specifically, the 113 
objectives of this work were to assess: 1) if those wastewater ARB and the respective 114 
ARGs were outcompeted in the presence of the human fecal microbiota, 2) if the cell-free 115 
ARGs could persist in that environment, and 3) the influence of the presence of oxygen 116 
or of antibiotics on the survival and persistence of the ARB and ARGs measured in 1) 117 
and 2). Assuming successful colonization, for which it is necessary that the exogenous 118 
enteric bacteria can thrive in the presence of fecal material, an additional question is if 119 
the acquired ARGs will be lost because represent a fitness cost. 120 
 121 
2. Material and methods 122 
The survival of wastewater antibiotic resistant isolates and persistence of the respective 123 
ARGs was assessed in the presence of the complex human fecal microbial community. 124 
The experiments were conducted in FMAs composed of human stool specimens spiked 125 
with two wastewater isolates: E. coli strain A2FCC14 (harboring the ARGs blaTEM, 126 
blaCTX and blaOXA-A) and Ent. faecium strain H1EV10 (harboring the ARG vanA), or with 127 
the respective DNA extracts. The environmental variables tested in the FMAs were 128 
aerobic vs. anaerobic conditions, and the effect of single or multiple doses of sub-129 
inhibitory concentrations of cefotaxime or vancomycin, under anaerobic conditions. The 130 
FMAs were incubated at 37 ºC, and samples were collected at 0, 1, 3 and 7 days. 131 
Monitoring was based on the enumeration of culturable bacteria, quantitative PCR 132 
(qPCR) analysis of antibiotic resistance and 16S rRNA genes and bacterial community 133 
analyses based on 16S rRNA gene amplicon sequencing. 134 
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 135 
2.1. Bacterial strains 136 
The strains E. coli A2FCC14 (isolated from raw municipal wastewater) and Ent. faecium 137 
H1EV10 (isolated from untreated hospital effluent) (Varela et al., 2013) were used to 138 
inoculate the fecal microcosm assays (FMAs). The Whole Genome Shotgun projects of 139 
strains A2FCC14 and H1EV10 have been deposited at DDBJ/ENA/GenBank under the 140 
accession numbers WSZB00000000 and WSZC00000000, respectively. These strains 141 
have an Average Nucleotide Identity (ANI) of orthologous gene pairs shared between two 142 
microbial genomes with the type strains of the species of 98.5% and 99.5%, respectively. 143 
ARGs conferring resistance to beta-lactam (blaTEM, blaCTX-M, and blaOXA-A), harbored by 144 
the E. coli strain and to vancomycin (vanA) harbored by the Ent. faecium strain were 145 
monitored in FMAs. For inoculum preparation, both strains were handled as follows: E. 146 
coli A2FCC14 was cultivated on m-FC agar medium (fecal coliform agar, Difco BD) 147 
supplemented with cefotaxime 4 mg L-1 and incubated overnight at 37 °C and Ent. 148 
faecium H1EV10 was cultivated on m-Enterococcus agar medium (Difco BD) 149 
supplemented with vancomycin 16 mg L-1 and incubated for 48 hours at 37 °C. The 150 
biomass collected from each of those bacterial cultures was used to prepare a bacterial 151 
suspension in saline solution (0.85% (w/v) NaCl) with a cell density of approximately 152 
108 and 107 Colony Forming Units (CFU) mL-1 for E. coli A2FCC14 and Ent. faecium 153 
H1EV10, respectively. This cell density was in accordance with the average density of 154 
bacteria of these groups in the human microbiome and although higher than can be 155 
expected from a possible ingestion and digestion, it overcomes the experimental risk of 156 
reaching the values below the limits of quantification. After an initial calibration of CFU 157 
versus turbidity at 610 nm, the cell suspensions used to inoculate each FMA were 158 
measured by spectrophotometry. 159 
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 160 
2.2. Feces-based microcosm assays (FMAs)  161 
The FMAs prepared with fecal material of a healthy child were used as a model to assess 162 
the fate of ARB and ARGs. All assays used fecal material supplied by a single healthy 163 
donor, aged 40 to 58 months during this study, and who was never submitted to 164 
antibiotherapy. The option for a donor with these characteristics was because although 165 
the gut microbiota was certainly affected by diet and lifestyle, it was not rearranged due 166 
to previous antibiotic exposure, a control considered relevant for the present experimental 167 
design. In total, were collected twelve stool samples, each used to run an independent 168 
FMA (Table 1). For each FMA experiment, were collected ≥ 80 g of fecal material that 169 
was stored at 4 °C for no more than 3 days. Each FMA comprised inoculated assays (M-170 
assays) and the respective non-inoculated controls (C-assays). FMAs were tested under 171 
aerobic and anaerobic conditions or under anaerobic conditions spiked with antibiotics. 172 
The evaluation of the effect of oxygen was considered of interest given the fact that E. 173 
coli are facultative anaerobes and enterococci are aerotolerant, supporting some inference 174 
about the influence of the fitness of these exogenous bacteria versus the effect of 175 
competition by the fecal microbiota. In total, four FMAs were incubated under aerobic 176 
conditions [40 (C and M); 44 (C and M); 48 (C and M); 50 (C and M)], three under 177 
anaerobic conditions [50 (C and M); 54 (C and M); 58 (C and M)] and four under 178 
anaerobic conditions, spiked with subinhibitory concentrations of antibiotics. Antibiotic 179 
spiking was done in a single-dose [54-C+cefotaxime (54-C.C), 54-C+vancomycin (54-180 
C.V), 54-M+cefotaxime (54-M.C) and 54-M+vancomycin (54-M.V)] or in multiple-181 
doses [58-C+cefotaxime (58-C.C), 58-C+vancomycin (58-C.V), 58-M+cefotaxime (58-182 
M.C) and 58-M+vancomycin (58-M.V)] (Table 1). Anaerobic FMAs were handled and 183 
incubated in an anaerobic chamber (Whitley Workstation A35, containing a gas mixture 184 
of 85% carbon dioxide, 10% nitrogen, 5% hydrogen). Each experimental set (FMA) 185 
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comprised 24 vial assays, corresponding to triplicates of spiked and non-spiked assays to 186 
be sacrificed for analyses after 0, 1, 3 and 7 days of incubation (3 replicates x spiked/non-187 
spiked x 4 incubation periods). Although the transit time of bacteria in the large intestine 188 
is estimated to be ~2.5 days, ingested bacteria can be detected in the intestine for one 189 
week (Berg 1996; Derrien and van Hylckama Vlieg 2015). Based on this note and 190 
preliminary assays, an incubation period of 7 days (extended to 30 days for occasional 191 
analysis) was selected.  192 
To prepare these experimental sets, stool samples were diluted five times with sterile 193 
saline solution (0.85% (w/v) NaCl) and divided in 24 aliquots of 15 mL each. Half of 194 
these 24 aliquots were inoculated with 2 mL of a bacterial cocktail, described in the 195 
previous section, composed by the mixture of both strains, E. coli A2FCC14 and Ent. 196 
faecium H1EV10 (M-assays). The other half of the aliquots, corresponding to non-197 
inoculated controls (C-assays), was spiked with 2 mL of sterile saline solution. FMAs 40, 198 
44 and 48 were incubated aerobically. FMA50 comprised two parallel FMAs (24 vials 199 
incubated aerobically and 24 anaerobically). FMA54 and FMA58 were incubated 200 
anaerobically and were spiked with antibiotics. Briefly, FMA54 comprised 24 vials 201 
without antibiotic, 24 spiked with one dose of cefotaxime (4 mg L-1 for each microcosm) 202 
and 24 spiked with one dose of vancomycin (16 mg L-1 for each microcosm). FMA58 203 
differed from FMA54 on the method of antibiotic spiking which in FMA58 was supplied 204 
at three antibiotic moments (3 x 4 mg L-1 for cefotaxime or 3 x 16 mg L-1 for vancomycin) 205 
at time 0, 1 day and 3 days, before each sample collection. Cell-free DNA supplemented 206 
FMAs, FMA44 and FMA48, were spiked with DNA extracts from E. coli A2FCC14 and 207 
Ent. faecium H1EV10. The DNA fragment length of the DNA extract of E. coli A2FCC14 208 
was assessed in an agarose gel (1 %) electrophoresis, originating a single band with a 209 
molecular weight 10-50 000 bp, with no smearing effect, which would suggest that DNA 210 
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was degraded. The quantity of DNA used was 2.0 and 1.5 µg of DNA extracted from E. 211 
coli A2FCC14 and Ent. faecium H1EV10, corresponding to the cell density used in the 212 
ARB inoculated FMAs (Table 1). FMA44 was designed aiming at assessing the 213 
persistence of the spiked free DNA and FMA48 aimed at assessing the potential 214 
occurrence of natural transformants, able to uptake the free DNA. Therefore FMA48 was 215 
composed of 3 separated assays (6 vial assays corresponding to triplicates of non-spiked 216 
assays, sampled at T0 and T7, 6 vial assays corresponding to triplicates of bacteria-spiked 217 
assays, sampled at T0 and T7 and, 6 vial assays corresponding to triplicates of assays 218 
spiked with cell-free DNA extracted from the test bacteria, sampled at T0 and T7). 219 
Natural transformants were tentatively isolated on the m-FC or m-Enterococcus culture 220 
media supplemented with antibiotic (cefotaxime or vancomycin, respectively). Cultivable 221 
bacteria counts were processed immediately, and aliquots for dry weight determination 222 
and total DNA extraction were stored at -20 and -80 ºC, respectively, until used. All 223 
determinations were done in triplicate. The stool dry weight was determined in 1 mL fecal 224 
slurry samples by incubation at 60 ºC, until a constant weight was reached, which 225 
corresponded to approx. 5 days. This study was approved by the Ethics Committee of the 226 
Universidade Católica Portuguesa in Porto. 227 
 228 
2.3. Enumeration of cultivable bacteria in FMAs 229 
Luria-Bertani Agar (LA) (Invitrogen), m-FC agar (Difco BD) and m-Enterococcus agar 230 
(Difco BD) were used for enumeration of total heterotrophic bacteria (HB), enterobacteria 231 
and enterococci, respectively. When necessary, these culture media were supplemented 232 
with cefotaxime (4 mg L-1; Sigma-Aldrich, St Louis, USA) or vancomycin (16 mg L-1; 233 
Sigma-Aldrich, St Louis, USA), at concentrations corresponding to minimum inhibitory 234 
concentration (MIC) for E. coli or enterococci (CLSI 2014). For bacterial enumeration, 235 
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volumes of 1 mL were collected from each FMA, serially diluted in sterile saline solution 236 
(0.85% (w/v) NaCl) and plated on the adequate culture medium using the Miles and Misra 237 
method (Miles et al., 1938). Cultures were incubated at 37 ºC for 24 h on LA and m-FC, 238 
or 48 h on m-Enterococcus agar. All bacterial counts were performed in triplicate.  239 
 240 
2.4. DNA extraction 241 
Total DNA was extracted from 1 mL of fecal slurry (corresponding to approximately 240 242 
mg of wet sedimented stool) using the NZY Tissue gDNA Isolation kit (Nzytech, 243 
Portugal) according to the manufacturer’s instructions. The DNA concentration in the 244 
extracts was quantified using Qubit fluorometer (Thermo Fisher Scientific, USA). 245 
Extracts were preserved at -20 ºC until qPCR or microbial community analyses were 246 
performed. 247 
 248 
2.5. Quantitative PCR 249 
The abundance of the genes blaTEM, blaCTX, blaOXA-A and vanA, harbored by the 250 
inoculated bacteria, was monitored based on real-time quantitative PCR (qPCR). The 251 
total bacterial abundance was assessed based on the housekeeping gene 16S rRNA. The 252 
qPCR was conducted in a StepOne™ Real-Time PCR System (Life Technologies, 253 
Carlsbad, CA) following the conditions previously described (Narciso-da-Rocha et al., 254 
2018) for the ARGs blaTEM, blaCTX and blaOXA-A and the 16S rRNA gene. The qPCR 255 
conditions for the detection of the gene vanA were set up in 25 µL volume using the 256 
Power SYBR Green mastermix (Thermo Fisher Scientific, Austin, USA) containing 10 257 
µM of each primer: VnF 5’-ATCGGCAAGACAATATGACAGC-3’ and VnR 5’-258 
AGCCTGATTTGGTCCACCTC-3’ (Lata et al., 2009). The PCR program was initiated 259 
by a period of 5 min at 95 °C, followed by 40 cycles of 95 °C for 15 sec and 60 °C for 30 260 
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sec. The standard curve for vanA gene was prepared using a clone of the vanA gene of 261 
Ent. faecium H1EV10 with an efficiency between 96 and 105%.  262 
 263 
2.6. Bacterial community analysis 264 
The bacterial community composition of FMA40, 44, 50, 54 and 58 was analyzed at time 265 
zero (T0) and after 7 days of incubation (T7), based on the hypervariable region V3/V4 266 
of the 16S rRNA gene, using paired-end Illumina MiSeq® Sequencing (Genoinseq, 267 
Portugal) as previously described by Narciso-da-Rocha et al. (2018). The primers used 268 
were forward primer Bakt_341F 5’- CCTACGGGNGGCWGCAG -3’ and reverse primer 269 
Bakt_805R 5’- GACTACHVGGGTATCTAATCC -3’ according to the manufacturer’s 270 
instructions (Illumina, San Diego, CA, USA). Demultiplexed raw reads were extracted 271 
from Illumina MiSeq® System in fastq format and the reads were processed and analyzed 272 
using Quantitative Insights Into Microbial Ecology (QIIME2) pipeline (version 2017.10; 273 
http://qiime2.org/) (Bolyen et al., 2018). Sequences shorter than 200 bp and with average 274 
quality scores lower than 25 were eliminated. Sequences with average quality lower than 275 
25 in a window of 5 bases were trimmed using the software PRINSEQ (Schmieder and 276 
Edwards 2011). Sequences were filtered, merged and, chimeric reads were removed by 277 
the DADA2 software package enclosed in QIIME2 (Callahan et al., 2016). Taxonomy 278 
was assigned to the amplicon sequence variants (ASVs), sequences with 100% identity, 279 
using the ARB SILVA database release 132 (Yilmaz et al., 2014). A total of 4 750 244 280 
reads (ranging from 22 176 to 112 134 reads per sample) and 1714 ASVs (ranging from 281 
171 to 263 per sample) were obtained from the 105 datasets, corresponding to triplicates 282 
of 35 samples of C and M FMAs. 283 
 284 
2.7. Statistical analyses 285 
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Cultivable bacteria counts were expressed as log values of colony-forming units (CFUs) 286 
per g of stool dry weight . Gene abundance was expressed as gene copy number per g of 287 
dry weight (abundance) or per 16S rRNA gene copy number (relative abundance or 288 
prevalence). One-way analysis of variance (ANOVA), Tukey's and Bonferroni post-hoc 289 
tests and t-test (SPSS Statistics for Windows v.24.0; IBM Corp., Armonk, NY, USA) 290 
were used for determination of statistically significant differences (p < 0.01) of cultivable 291 
bacteria counts, abundance and prevalence of measured genes when comparing different 292 
incubation times or conditions. The bacterial community composition was expressed as 293 
the relative abundance of reads number of a specific bacterial group per total reads 294 
number. Correlations between the relative abundance of bacterial groups at phylum and 295 
family level were analyzed using the statistical analysis of taxonomic and functional 296 
profiles using the software STAMP v2.1.3 and Canoco 5.01 (Parks et al., 2014; Šmilauer 297 
and Lepš 2014). Statistically significant differences between bacterial phyla or family 298 
relative abundances were determined using a two-tailed t-test (p <0.01) and the p values 299 
were corrected for multiple testing using the Benjamini-Hochberg FDR (Benjamini and 300 
Hochberg 1995).  301 
 302 
3. Results and discussion  303 
3.1. Microbial community composition of the fecal material  304 
Since the fecal microbiota composition and the respective temporal variations could 305 
somehow influence the fate of exogenous ARB and ARGs, the analysis of the fecal 306 
bacterial community was necessary in this study. This part of the work had two aims, 307 
assess the phylogenetic diversity in the fecal material and assess the variations that were 308 
due to the microcosm effect. Over the study period, the infant (40-58 months) fecal 309 
microbiota was dominated by members of the bacterial phyla Firmicutes (41.6-47.1%) 310 
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and Bacteroidetes (23.5-36.2%), followed by Actinobacteria (7.2-22.5%), 311 
Proteobacteria (1.5-7.4%) and Verrucomicrobia (1.2-7.4%) (Table S1). These results are 312 
in line with similar studies involving healthy individuals in the same age range (Monira 313 
et al., 2011). Statistically significant variations were observed over the study period for 314 
all the above mentioned phyla, although none with a clear trend of increase or decrease. 315 
These variations might be due to diet and/or the natural dynamic processes observed in 316 
infants gut microbiota (Milani et al., 2017; Zmora et al., 2019). Although these variations 317 
were smooth and with little expected impacts on the survival of the exogenous bacteria, 318 
whenever adequate they will be used to discuss the results. 319 
 320 
3.2 Effect of incubation condition on the microbial community composition 321 
The microcosm effect, meaning the bacterial community variations that occurred during 322 
the incubation period (7 days), which could allegedly influence the survival or persistence 323 
of exogenous bacteria or their ARGs, was assessed in non-inoculated FMAs, under both 324 
aerobic and anaerobic conditions. Besides the variation of phyla composition, it was also 325 
assessed the variation in the relative abundance of members of the families that include 326 
the wastewater ARB surrogates used in the inoculated FMAs, Enterobacteriaceae and 327 
Enterococcaceae (Table 2). The relative abundance of Proteobacteria significantly 328 
(p<0.01) increased (ratio T7/T0 > 1) during the incubation under aerobic, but not under 329 
anaerobic conditions (Table 2). It was also observed that the relative abundance of 330 
Enterobacteriaceae in the non-inoculated assays was always higher than in inoculated 331 
microcosms (Table 2), which might be due to a steady-state-like for Enterobacteriaceae 332 
in the fecal microbial community, in which these bacteria, in equilibrium with the 333 
remaining community, are kept at a certain level and eventually exogenous bacteria, as 334 
were the wastewater isolates in this case, may have a limited proliferation capacity.  335 
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The relative abundance of the bacterial phylum Firmicutes was fairly stable over the 7 336 
days period, under both aerobic and anaerobic conditions, with the ratio T7/T0 varying 337 
between 0.65 and 0.99 in non-inoculated FMAs (Table 2). Curiously, members of family 338 
Enterococcaceae, of the phylum Firmicutes, were not detected in non-inoculated FMAs.  339 
The observation that anaerobic conditions had a lower impact on the microcosm effect 340 
than aerobic conditions, mainly in the groups that include the surrogates used, 341 
recommended that the effect of antibiotics would be better examined under anaerobiosis. 342 
In the FMA54 and FMA58, the addition of cefotaxime or vancomycin only affected 343 
significantly (p<0.01) the relative abundance of Proteobacteria (Table S3). Curiously, 344 
this effect was different when a single- (FMA54) or multiple-antibiotic-dose (FMA58) 345 
was used (Table S3). A single cefotaxime dose (54-C.C and 54-M.C) significantly 346 
(p<0.01) reduced the relative abundance of Proteobacteria in both inoculated and non-347 
inoculated FMAs (ratio antibiotic/no antibiotic < 1). In contrast, multiple cefotaxime 348 
doses led to a significant (p<0.01) reduction on the relative abundance of Proteobacteria 349 
only in inoculated FMAs (58-M.C). The use of a single vancomycin dose significantly 350 
(p<0.01) reduced the relative abundance of Proteobacteria in the non-inoculated samples 351 
(54-C.V; Table S3). In contrast, three doses of vancomycin led to a significant (p<0.01) 352 
increase of the Proteobacteria relative abundance, only in non-inoculated FMA (58-C.V). 353 
As noted above for oxygen, also the antibiotic effect on members of the 354 
Enterobacteriaceae followed the same pattern as for the Proteobacteria phylum (Table 355 
S3). In contrast, no noticeable effects of antibiotics were observed on Enterococcaceae 356 
in inoculated FMAs. 357 
These different behaviors of the bacterial community in presence of a single or multiple 358 
doses of antibiotics may suggest the rearrangement of the community or the charity 359 
among community members that able to degrade the antibiotics. The Principal 360 
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Component Analysis (PCA) of the non-inoculated assays suggest that irrespective of the 361 
antibiotic and spiking method, members of the families Burkholderiaceae (phylum 362 
Proteobacteria) and Lachnospiraceae (phylum Firmicutes) were those whose relative 363 
abundance decreased during the incubation period. The contribution of these groups to 364 
the community rearrangement may have been exacerbated in the presence of antibiotics 365 
(Figure S1 A, B, C, and D). In general, the results suggest that antibiotics might have 366 
important effects on the fecal bacterial community composition and structure, with effects 367 
being noticed in the relative abundance of members of the phyla Firmicutes, 368 
Actinobacteria and Bacteroidetes (Table S3). The relative abundance of Actinobacteria 369 
was significantly lower in the fecal material used in the FMA where a single antibiotic 370 
dose was tested (FMA 54) than in that where three successive doses were assayed (FMA 371 
58). The opposite was observed for the relative abundance of Bacteroidetes (Table S1). 372 
Since both phyla members were observed to have strong correlation with antibiotic 373 
spiking, the distinct behavior observed in response to one or multiple antibiotic doses may 374 
be also a result of distinct microbiota composition. The importance of these bacterial 375 
groups as potential barriers or facilitators for antibiotic-induced bacterial community 376 
rearrangements may deserve further investigation. In general, the PCA results (Figure S1) 377 
are in agreement with the literature that suggests that the oral or intravenous antibiotic 378 
administration can promote the disturbance of the human gut microbiome (Bhalodi et al., 379 
2019; Francino 2016). The PCA analysis (Figure S1) suggests that the significant 380 
variations observed in Proteobacteria relative abundance (Table S3), might be due to 381 
complex fecal bacterial community rearrangements rather than to the increase or decrease 382 
of a specific bacterial lineage. Indeed, it is this type of indirect effect that was 383 
demonstrated for vancomycin, a glycopeptide antibiotic used against Gram-positive 384 
bacterial infection. In that case, it was associated with the decrease of Firmicutes that led 385 
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to the increase of Proteobacteria in the fecal microbial community (Isaac et al., 2017; 386 
Vrieze et al., 2014). Indeed, although there is no evidence specifically for vancomycin 387 
and cefotaxime, the ability of sub-inhibitory concentrations of antibiotics to modify the 388 
competition between bacterial species within a microbial community has been discussed 389 
(Hall and Corno 2014; Martinez 2009). 390 
 391 
3.3. Monitoring of culturable bacteria and antibiotic resistance genes 392 
The native and exogenous culturable populations of enterobacteria, enterococci and/or 393 
total heterotrophic bacteria were monitored over time and under distinct conditions. 394 
Heterotrophic and enterobacteria counts presented similar variation patterns in inoculated 395 
and non-inoculated FMAs and, in both cases, it was possible to infer about the beneficial 396 
oxygen effect on the first day of incubation, characterized by a slight CFU increase. 397 
Therefore, it is suggested that the fitness of enteric bacteria cannot be explained based 398 
only on the fecal microbiota competition, it is also explained by the survival capacity, in 399 
this case, higher in the presence of oxygen (Figure 1). In contrast, the behavior of the 400 
aerotolerant enterococci was identical in the presence or absence of oxygen. Also, 401 
enterococci counts presented a similar variation pattern in inoculated and non-inoculated 402 
assays (Figure 1). In general, under anaerobic conditions, enterococci, enterobacteria and 403 
heterotrophic bacteria counts presented in average reductions of 1.1, 1.0 and 0.1 log units 404 
over the 7 incubation days, respectively (Figure 1). However, the stochastic nature of 405 
these variations is suggested, when different FMAs are compared (Figure 1).  406 
The exogenous bacteria were wastewater isolates, E. coli A2FCC14 and Ent. faecium 407 
H1EV10, belonging to the multilocus sequence types ST131 and ST78, respectively, 408 
therefore genetically related with widespread pathogens (Khan et al., 2010; Nicolas-409 
Chanoine et al., 2014). These exogenous bacteria were traced based on their ARGs 410 
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blaTEM, blaCTX-M, blaOXA-A and vanA (Figure 2). Under aerobic conditions, the 16S rRNA 411 
gene abundance per gram of feces dry weight, decreased during the incubation period on 412 
average 0.26 log-units in inoculated FMAs (40-M and 50-M) and 0.32 log-units for non-413 
inoculated FMAs (40-C and 50-C). These values were comparatively higher under 414 
anaerobic conditions, of 0.48 log-units in inoculated FMAs (50-M, 54-M, and 58-M) and 415 
of 0.42 log-units in non-inoculated FMAs (50-C, 54-C and 58-C). 416 
Among the analyzed ARGs, only blaTEM was detected in non-inoculated microcosms 417 
(Figure 2). The blaTEM gene may have been ingested by the donor (e.g. fresh produce) 418 
(Blau et al., 2018), and its occurrence in the gut microbiota of healthy individuals, even 419 
if never exposed to antibiotics, has been reported (Fouhy et al., 2014; Sommer et al., 420 
2009). In general, the vanA gene abundance (per gram of dry weight) did not vary 421 
significantly from T0 to T7, with average measurements at T0 and T7 of 5.87 ± 0.11 and 422 
5.79 ± 0.15 log-units under aerobic conditions, and 7.34 ± 1.17 and 7.17 ± 1.12 log-units 423 
under anaerobic conditions (Figure 2). In contrast, occasionally, although under both 424 
aerobic and anaerobic conditions (40-M and 58-M, Figure S2) the prevalence of vanA 425 
(per 16S rRNA gene) increased significantly (p<0.01), which may be due to the decrease 426 
of the overall bacterial population, herein measured in 16S rRNA gene abundance. 427 
Aerobically, on average (FMAs 40-C, 50-C, 40-M and 50-M), the abundance of blaTEM 428 
gene had a significant (p<0.01) increase from 7.13 ± 0.55 log-units at T0 to 8.23 ± 0.44 429 
log-units at T7 (Figure 2). Anaerobically, blaTEM was not detected in one of the non-430 
inoculated assays (58-C) and it decreased significantly (p<0.01) in the FMA50 (50-C, 50-431 
M; Figure 2). In the FMA54, blaTEM gene increased and decreased significantly (p<0.01) 432 
in the non-inoculated and inoculated assays, respectively (54-C, 54-M; Figure 2). On the 433 
average of the FMAs (50-C, 54-C, 50-M, 54-M, and 58-M), its abundance varied from 434 
7.61 ± 1.12 log-units at T0 to 8.18 ± 0.74 log-units at T7 (Figure 2). The prevalence of 435 
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the blaTEM gene (per 16S rRNA gene) followed the same pattern of variation of the blaTEM 436 
gene abundance along time, which suggests that the variations of blaTEM gene are mainly 437 
due to total bacteria variations (Figure 2, Figure S2).  438 
The abundance (per gram of dry weight) of the blaCTX-M gene increased significantly 439 
(p<0.01) under aerobic incubation (40-M; Figure 2) ranging from 6.83 ± 0.15 to 7.80 ± 440 
0.05 log-units and, the same gene decreased significantly (p<0.01) under anaerobic 441 
incubation (50-M; Figure 2) varying from 7.04 ± 0.21 to 5.63 ± 0.46 log-units. Similar 442 
results were observed for blaOXA-A gene, which abundance (per gram of dry weight) varied 443 
significantly (p<0.01) from 6.37 ± 0.22 to 7.49 ± 0.06 log-units under aerobic conditions 444 
(40-M; Figure 2) and from 6.68 ± 0.14 to 5.75 ± 0.42 log-units under anaerobic conditions 445 
(50-M; Figure 2). 446 
In general, it was observed that the abundance of the beta-lactamase genes increased 447 
under aerobic conditions and decrease under anaerobic conditions (Figure 2). This result 448 
that is aligned with the enumeration of culturable bacteria, suggests that the fitness of the 449 
exogenous bacteria, and not only the competition by the native microbiota, may dictate 450 
the fate of enterobacteria in the FMAs. The prevalence (expressed per 16S rRNA gene 451 
copy number) of both blaCTX-M and blaOXA-A increased under aerobic (40-M, 50-M) and 452 
anaerobic conditions (54-M, 58-M, except 50-M) (Figure S2). Comparing the FMA-40 453 
and FMA-50 the abundance and prevalence of the blaCTX-M and blaOXA-A follows the same 454 
pattern suggesting that the variations of the beta-lactamase genes are mainly due to 455 
bacterial host variations (Figure 2, Figure S2).  456 
To test the hypothesis that the fate of the exogenous ARGs is mainly dictated by the 457 
survival and integrity of the host cell, cell-free DNA extracts were used for spiking the 458 
FMAs (FMA44). The ARGs blaCTX-M, blaOXA-A, and vanA, detected after inoculation at 459 
doses of 4-5 log units were below the detection limit after 1 day of incubation (Figure 2), 460 
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suggesting the rapid DNA degradation by the native fecal microbiota (e.g. extracellular 461 
enzymes or bacteria feeding in naked DNA). This result supported the hypothesis that 462 
viable or at least integer bacterial hosts are necessary to ensure the ARGs persistence. 463 
Moreover, any attempts to isolate transformants from free-DNA spiked FMA48 were 464 
unfruitful, therefore failing the evidence of antibiotic resistance acquisition by 465 
transformation.  466 
 467 
3.3.1 Antibiotics effect on exogenous antibiotic resistant bacteria  468 
Culturable enterococci showed a different pattern of variation in inoculated and non-469 
inoculated assays spiked with vancomycin, although in both was observed a significant 470 
(p<0.01) decrease along time (Figure 1). In the presence of a single-dose of cefotaxime 471 
(FMA54; Figure 1), culturable enterobacteria in inoculated and non-inoculated FMAs 472 
undergone a significant (p<0.01) decrease of approximately 2 log-units after 7 days. A 473 
similar, although less intense effect, was observed after administration of a multiple-dose 474 
of cefotaxime, with enterobacteria reductions of approximately 1 log-unit in inoculated 475 
and non-inoculated microcosms after a week (Figure 1). Generally, in the presence of low 476 
concentrations of cefotaxime or vancomycin, heterotrophic bacteria counts presented a 477 
similar trend along the time in both inoculated and non-inoculated microcosms (Figure 478 
1). Using a single-dose of cefotaxime (FMA 54-M.C, 54-C.C; Figure 1) or vancomycin 479 
(FMA 54-M.V, 54-C.V; Figure 1), heterotrophic bacteria counts of inoculated and non-480 
inoculated samples decreased significantly (p<0.01) of approximately 3 or 1 log-units, 481 
respectively, after 7 days. A similar, albeit less intense effect, was observed after 482 
administration of a multiple-dose of cefotaxime (FMA 58-M.C, 58-C.C; Figure 1) where 483 
heterotrophic bacteria counts of inoculated and non-inoculated assays decreased 484 
significantly (p<0.01) of approximately 2 log-units after 7 days. 485 
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The abundance of the 16S rRNA gene per gram of feces dry weight, a measure of bacterial 486 
abundance, was not significantly different in inoculated and non-inoculated assays, and 487 
decreased significantly (p<0.01) over the incubation period, in inoculated (from 11.45 ± 488 
0.19 to 10.88 ± 0.28 log-units; FMA 54-M.C, 54-M.V; FMA 58-M.C and 58-M.V) and 489 
in non-inoculated microcosms (from 11.38 ± 0.11 to 10.89 ± 0.11 log-units; FMA 54-490 
C.C, 54-C.V; FMA 58-C.C and 58-C.V), irrespective of the use of one or three doses of 491 
antibiotic (Figure 3). In the presence of one or three doses of cefotaxime or vancomycin, 492 
the abundance of vanA gene did not change significantly (FMA 54-M.C, 54-M.V; FMA 493 
58-M.C and 58-M.V; Figure 3). However, in the presence of one or three doses of 494 
cefotaxime the vanA per 16S rRNA gene copy number (prevalence) increased 495 
significantly (p<0.01) on average from -3.66 ± 0.04 to -3.27 ± 0.08 log-units in inoculated 496 
microcosms (FMA 54-M.C and FMA 58-M.C; Figure S3). Similarly, in the presence of 497 
three doses of vancomycin, the prevalence (per 16S rRNA gene) of vanA increased 498 
significantly (p<0.01) from -3.51 ± 0.06 to -2.95 ± 0.01. Since culturable enterococci 499 
decreased over this period, the observed increase is probably due to the sharp decrease of 500 
bacteria (16S rRNA gene abundance) observed during incubation. In the presence of one-501 
dose of cefotaxime, the abundance (per dry weight) of the ARGs blaTEM, blaCTX-M and 502 
blaOXA-A decreased significantly (p<0.01) (FMA 54-M.C; Figure 3) while in the presence 503 
of three-doses of cefotaxime, the abundance of these genes did not vary significantly 504 
(FMA 58-M.C; Figure 3). The prevalence (per 16S rRNA gene) of the ARGs blaTEM, 505 
blaCTX-M and blaOXA-A increased significantly (p<0.01), but only when three doses of 506 
cefotaxime were supplied (FMA 58-M.C; Figure S3).  507 
In the presence of one or three doses of vancomycin, the abundance (per dry weight) of 508 
the ARGs blaTEM significantly (p<0.01) decreased and of blaCTX-M significantly (p<0.01) 509 
increased, while the gene blaOXA-A no significant variations were observed (FMA 54-M.V 510 
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and FMA 58-M.V; Figure 3). The prevalence of blaTEM, blaCTX-M and blaOXA-A increased 511 
significantly (p<0.01) only in the presence of three doses of vancomycin (FMA 58-M.V; 512 
Figure S3). The abundance and prevalence of the genes blaTEM and blaCTX-M followed the 513 
same pattern of variation when vancomycin was supplemented at three doses suggesting 514 
that the variations of these two genes are mainly due to bacterial host variations. 515 
Nevertheless, the prevalence increment of the gene blaOXA-A in the presence of three-516 
doses of vancomycin suggests that this antibiotic might favor the survival or the 517 
persistence of bacteria harboring the blaOXA-A gene along the period of incubation. 518 
 519 
3.4 Relationship between bacterial community and antibiotic resistance genes 520 
To unravel the possible relationship between ARGs persistence and the variation of the 521 
fecal bacterial community in the presence of a single- or multiple-dose of cefotaxime or 522 
vancomycin, a Canonical Correspondence Analysis (CCA) was performed. This analysis 523 
confirmed the microbiota rearrangements due to the microcosm effect (Table 2) by the 524 
separation between T0 and T7 samples and highlighted the effects of antibiotics (Table 525 
S3, Figure S1) (T7 vs T7.C or T7.V, Figure 4). The use of a single- or multiple- antibiotic 526 
doses highlighted distinct patterns of correlation between the fecal bacterial community 527 
composition and the quantified genes. While with a single-dose, the ARGs variation was 528 
co-linear, with all genes showing the same pattern of variation (Figure 4 A and B), for 529 
multiple-doses were observed distinct patterns of variation (Figure 4 C and D). With a 530 
single cefotaxime or vancomycin dose, the quantified genes were correlated with groups 531 
observed to decrease over the incubation period such as Ruminococcaceae and 532 
Burkholderiaceae (for cefotaxime), and Lachnospiraceae (for both antibiotics), as could 533 
be observed over axis 1, which explains >85% of the variation. The use of multiple doses 534 
of cefotaxime or of vancomycin produced distinct correlation patterns. For three 535 
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cefotaxime doses, the genes 16S rRNA, blaCTX-M and blaTEM had a co-linear variation and 536 
were correlated with the decrease during incubation of populations such as 537 
Lachnospiraceae, as can be seen over axis 1 that explains >70% of the variation. The 538 
variation of the genes blaOXA-A and vanA was co-linear and negatively correlated with 539 
Firmicutes of the families Christensenellaceae and Enterococcaceae (Figure 4C). For 540 
three vancomycin doses, the 16S rRNA gene was positively correlated with the 541 
Lachnospiraceae and Burkholderiaceae, as can be observed over axis 1 explaining >88% 542 
of the variation. With opposite distributions over axis 2 that explains < 8% of variation 543 
were the genes blaOXA-A and vanA, blaCTX-M and blaTEM with a co-linear variation. The 544 
three latter were positively correlated with Tannerellaceae (phylum Bacteroidetes) and 545 
the Enterococcaceae, Acidaminococcaceae and Christensenellaceae (phylum 546 
Firmicutes) (Figure 4 D). 547 
This study aimed at assessing if ARGs harbored by exogenous wastewater ARB in fecal 548 
material and if aerobiosis or antibiotics could influence their survival. The rationale was 549 
that variations of exogenous bacteria could be due to their fitness or due to the influence 550 
of the fecal microbiota rearrangements, or both. Previous studies have shown that 551 
enterobacteria spiked in animal feces can maintain viability for up to three months in 552 
ambient air (Scott et al., 2006; Segura et al., 2018; Sinton et al., 2007; Walters and Field 553 
2009). In the present study, it was used a period of 7 days, considering this would be an 554 
acceptable time period for transient intestinal colonization with wastewater ARB. The 555 
PCA and CCA results suggest that exogenous bacteria survival or proliferation is 556 
unpaired by the autochthonous fecal microbiota, mainly Firmicutes and Bacteroidetes 557 
families. However, the assayed exogenous bacteria could not be eliminated until 7 days 558 
and their genes could be detected in FMAs incubated for 30 days (data not shown). 559 
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Overall these results suggest that: i) the fate of ARGs is mainly determined by the fitness 560 
of the host bacteria; ii) in spite of the ARGs host decay, the overall decrease of the fecal 561 
bacterial population (e.g. due to adverse conditions or antibiotherapy) may lead to 562 
apparent increases of ARGs prevalence, and iii) even if ARGs host cells lose viability 563 
they may protect the ARGs, as long as cells integrity is maintained. The role of the 564 
competitor native fecal microbiota is unquestionable, and it may be influenced by both 565 
diversity and abundance. Although it is difficult to estimate the likelihood of transmission 566 
of wastewater-ARB to humans, the fact that these may be able to survive the competition 567 
by native microbiota is a topic that should not be neglected.  568 
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Figure 1. Colony forming units (CFUs) enumeration per gram of dry weight of stool 
samples, non-inoculated (C, dashed grey lines with empty symbols) or ARB-inoculated 
(M, solid colorful lines with full symbols) for FMAs incubated under aerobic (column on 
the left hand side) and anaerobic (column in the middle) conditions, and in the presence 
of antibiotics (column on the right hand side). FMA54 were performed in the presence of 
a single-dose of cefotaxime (54-M.C, blue squares) or vancomycin (54-M.V, blue 
triangles), while FMA58 were conducted in the presence of multiple-doses of cefotaxime 
(58-M.C, green circles) or vancomycin (58-M.V, green rhombus). CFUs were 
enumerated on m-Enterococcus, m-FC and LA medium for enterococci, enterobacteria 
and heterotrophic bacteria (HB) counts, respectively. The CFU values are the average of 
triplicates with the standard deviation. Note: At T0 of FMA-54 and FMA-58, the log 
CFUs on antibiotic supplemented culture media per gram of feces dry weight of the ARB-
inoculated FMAs was 9.03 ± 0.11 and 9.13 ± 0.14 (54 and 58) on mFC agar with 
cefotaxime and, 8.55 ± 0.06 and 8.47 ± 0.55 (54 and 58) on m-Enterococcus agar with 
vancomycin, being below the detection limit in non-inoculated controls. At time 7 days 
of FMA-54 and FMA-58, the log CFUs on antibiotic supplemented culture media per 
gram of feces dry weight of the ARB-inoculated FMAs was 6.38 ± 0.07 and 8.06 ± 0.12 
(54 and 58) on mFC agar with cefotaxime and, 7.40 ± 0.07 and 6.58 ± 0.08 (54 and 58) 
on m-Enterococcus agar with vancomycin, being below the detection limit in non-
inoculated controls. 
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Figure 2. Variation of 16S rRNA and antibiotic resistance genes over time. The 
abundance of the genes (vanA, blaOXA-A, blaCTX-M, blaTEM, and 16S rRNA) per g of dry 
weight of stool, of non-inoculated (C) and ARB-inoculated (M) FMAs under aerobic 
(column on the left side) and anaerobic (column on the right) conditions is shown. The 
variation of each gene along time among each FMA is indicated by colored boxplot 
graphs (blue, red, green and orange corresponding to 0, 1, 3 and 7 days, respectively). 
The FMAs 40-C, 40-M, 50-C and 50-M were performed aerobically. The FMAs 50-C, 
50-M, 54-C, 54-M, 58-C and 58-M were performed in anaerobic condition. With 
exception of the gene blaTEM, the ARGs blaCTX, blaOXA-A and vanA were not detected in 
the non-inoculated microcosms. However, the gene blaTEM was not detected in the non-
inoculated microcosms 58-C. Genes abundance are the average values of all FMAs 
replicates with the standard deviation. Stars indicate statistically significant variation 
(p<0.01) of the genes abundance between T0 and T7 for each FMA.  
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In cell-free DNA supplemented FMAs, FMA44 and FMA48, the spiked genes (in log 
copy number per gram of stool dry weight) were 5.92 ± 0.09 for blaCTX-M, 5.99 ± 0.43 for 
blaOXA-A, and 4.02 ± 0.13 for vanA and 9.24 ± 0.30 for blaTEM, a value that might be 
overestimated, given the natural occurrence of this gene in the non-inoculated 
microcosms. After one day of incubation the blaCTX-M,  blaOXA-A, and vanA genes were 
below the limit of quantification. 
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Figure 3. Effect of antibiotic on the variation of 16S rRNA and antibiotic resistance genes 
along the time. The abundance of the genes (vanA, blaOXA-A, blaCTX-M, blaTEM and 16S 
rRNA) per g of dry weight of stool, of non-inoculated (C) and ARB-inoculated (M) FMAs 
under anaerobic conditions in the presence of antibiotics is shown. The variation of each 
gene along time for each FMA is indicated by colored boxplot graphs (blue, red, green 
and orange corresponding to 0, 1, 3 and 7 days, respectively). FMAs were performed in 
the presence of a single-dose of cefotaxime (54-C.C, 54-M.) or vancomycin (54-C.V, 54-
M.V) or, in the presence of multiple-doses of cefotaxime (58-C.C, 58-M.C) or 
vancomycin (58-C.V, 58-M.V). The ARGs blaTEM , blaCTX, blaOXA-A and vanA were not 
detected in the non-inoculated microcosms. Genes abundance are the average values of 
all FMAs replicates with the standard deviation. Stars indicated statistically significant 
variation (p<0.01) of genes abundance between T0 and T7 for each FMA. 
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Figure 4. Canonical Correspondence Analysis (CCA) of bacterial families (with relative 
abundance > 1%, and with the highest fit values, > 0.90) of the ARB-inoculated assays in 
the presence of a single-dose of cefotaxime (A) or vancomycin (B) or, in the presence of 
a multiple-dose of cefotaxime (C) or vancomycin (D). All the CCA represent microcosms 
at the beginning (T0) and after seven days of incubation (T7) without antibiotic (black 
circle and light blue circle, respectively), T0 and T7 in the presence of a single-dose of 
cefotaxime (T0.C, yellow circle; T7.C, green circle) or vancomycin (T0.V, yellow circle; 
T7.V, green circle) and, T0 and T7 in the presence of a multiple-dose of cefotaxime 
(T0.C, yellow circle; T7.C, purple circle) or vancomycin (T0.V, yellow circle; T7.V, 
purple circle). The red arrows show the significant explanatory variables (p<0.05) while 
grey arrows represent the explanatory variables with no significant correlation. 
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Table 1. Composition and conditions of the different microcosm assays. Each FMA 
comprised 24 vials (12 non-inoculated - C and 12 inoculated - M).  
 
Experiment 
      Inoculum         Conditions used for each assay   
16S rRNA 
based 
microbiome 
analysis 
 
ARB (cell density OD610) 
 
Free-DNA 
 
Oxygen availability 
 
Antibiotic presence  
FMA  
E. coli       
A2FCC14            
cell density 
(approx. 
CFU mL-1)  
Enterococcus 
sp. H1EV10               
cell density 
(approx. 
CFU mL-1) 
 
E. coli      
A2FCC14 
(µg) 
Enterococcus 
sp. H1EV10         
(µg) 
 Aerobic  Anaerobic   
Cefotaxime 
(4 mg L-1) 
Vancomycin 
(16 mg L-1) 
  
  
40-C   - -   - -   + -   - -  T0; T7 
40-M   107 106   - -   + -   - -   T0; T7 
44-C   - -   - -   + -   - -  T0; T7 
44-M   - -   2.0 1.5   + -   - -   T0; T7 
48-C   - -   - -   + -   - -    
48-M  107 106  - -  + -  - -    
48-M   - -   2.0 1.5   + -   - -     
50-C   - -   - -   + -   - -  T0; T7 
50-M  107 106  - -  + -  - -  T0; T7 
50-C  - -  - -  - +  - -  T7 
50-M   107 106   - -   - +   - -   T0; T7 
54-C   - -   - -   - +   - -  T0; T7 
54-M  107 106  - -  - +  - -  T0; T7 
54-C.C  - -  - -  - +  + (1 dose) -  T7 
54-M.C  107 106 
 
- -  - + 
 
+ (1 dose) -  T0; T7 
54-C.V 
 
- - 
 
- - 
 
- + 
 
- + (1 dose)  T7 
54-M.V   10
7 106   - -   - +   - + (1 dose)   T0; T7 
58-C   - -   - -   - +   - -  T0; T7 
58-M  107 106  - -  - +  - -  T0; T7 
58-C.C  - -  - -  - +  + (3 doses) -  T7 
58-M.C  107 106 
 
- -  - + 
 
+ (3 doses) -  T0; T7 
58-C.V 
 
- - 
 
- - 
 
- + 
 
- + (3 doses)  T7 
58-M.V 
  
107 106 
  
- - 
  
- + 
  
- + (3 doses)   T0; T7 
C, control - non-inoculated assay; C.C, control spiked with cefotaxime; C.V, control 
spiked with vancomycin. M, ARB-inoculated assay; M.C, ARB-inoculated assay spiked 
with cefotaxime; M.V, ARB-inoculated assay spiked with vancomycin. 
T0, beginning; T7, seven days of incubation. 
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Table 2. Microcosm effect in fecal microcosm assays (FMAs) based on a single healthy donor aged 40, 44, 50, 54 and 58 months. Control, non-
inoculated (C), and test, ARB-inoculated (M), FMAs incubated under aerobic (40-C, 40-M; 44-C, 44-M; 50-C, 50-M) or anaerobic (50-C, 50-M; 
54-C, 54-M; 58-C, 58-M) conditions. Phyla with relative abundance equal or below 2% are designated as other phyla. The values correspond to 
the ratio of relative abundance (number of reads/total number of reads) of each replicate at T7 of C or M per the average values of the relative 
abundance at the respective T0 of C or M. The values are expressed as the average of triplicates ± the standard deviation. 
FMAs Condition Phylum relative abundance at T7/ phylum relative abundance at T0 
Family relative abundance at T7/ 
family relative abundance at T0 
  
Aerobic 
Bacteroidetes Actinobacteria Verrucomicrobia Firmicutes Proteobacteria Other phyla (≤ 2%) Enterobacteriaceae Enterococcaceae 
40-C 0.85±0.01* 1.02±0.02 0.80±0.08 0.78±0.01* 7.53±0.44* 24.94±0.71 51.90±9.43* n.d. 
40-M 0.90±0.02* 1.10±0.06 1.47±0.26 0.82±0.04* 4.81±0.59* 2.81±0.69 20.08±4.26* 0.69±0.14 
            
44-C 1.06±0.03 1.77 ±0.05* 1.43±0.08* 0.65±0.01* 1.62±0.10* 3.12±0.74 3.05±0.14* n.d. 
44-M 1.12±0.05* 1.54±0.19* 1.41±0.07* 0.62±0.03* 1.62±0.04* 3.69±0.29 2.86±0.19* 0.26±0.45 
            
50-C 0.79±0.05 1.13±0.06 0.64±0.07 0.99±0.09 4.83±1.02* 1.70±0.29 27.59±6.48* n.d. 
50-M 0.86±0.03 1.18±0.03 0.62±0.13 0.90±0.01 4.95±0.16* 2.18±0.46 20.72±0.38* 4.75±0.17* 
              
50-C 
Anaerobic 
0.94±0.02 1.39±0.07 0.43±0.09 0.98±0.00 0.39±0.01* 2.16±0.08 0.36±0.08* n.d. 
50-M 0.93±0.09 1.44±0.19 0.47±0.13 0.96±0.01 0.33±0.05* 1.00±0.19 0.31±0.02 6.31±0.18* 
            
54-C 0.91±0.03 1.59±0.14* 0.65±0.08* 0.83±0.04* 2.18±0.25* 1.40±0.44 28.80±3.51* n.d. 
54-M 0.98±0.03 1.32±0.13* 0.83±0.18 0.89±0.03* 0.70±0.10* 2.86±0.71 1.34±0.23 1.14±0.15 
            
58-C 1.09±0.02 1.24±0.02* 1.28±0.18 0.81±0.01* 0.96±0.21 1.53±0.18 48.37±17.22* n.d. 
58-M 1.06±0.06 1.31±0.13 1.09±0.12 0.74±0.04* 2.46±0.43* 1.78±0.38 6.56±1.33* 3.91±0.45* 
n.d., not detected both at T0 and T7. 
*; statistically significant variation (p<0.01) between T0 and T7 for each FMA
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Table 3. Antibiotic effect on non-inoculated (C) and ARB-inoculated (M) FMAs exposed to the addition of a single- (54-C.C, 54-M.C, 54-C.V, 
and 54-M.V) or a multiple-dose (58-C.C, 58-M.C, 58-C.V, and 58-M.V) of antibiotic. Legend: 54-C or 54-M and 58-C or 58-M, non-inoculated 
(C) or ARB-inoculated (M) FMA without addition of antibiotics; 54-C.C or 54-M.C and 58-C.C or 58-M.C, FMAs with addition of a single- or a 
multiple-dose, respectively, of cefotaxime (4 mg L-1); 54-C.V or 54-M.V and 58-C.V or 58-M.V, FMA with addition of a single- or a multiple-
dose, respectively, of vancomycin (16 mg L-1). Phyla with relative abundance equal or below 2% were designated as other phyla. The values 
correspond to the ratios of the relative abundance of each replicate at T7 of C or M in the presence of antibiotic and, the average values of the 
relative abundance at T7 of C or M without the addition of antibiotics. The values are expressed as the average of triplicates ± the standard deviation. 
FMAs Conditions Phylum relative abundance with antibiotic/ phylum relative abundance without antibiotic 
Family relative abundance with 
antibiotic/ family relative abundance 
without antibiotic 
    Bacteroidetes Actinobacteria Verrucomicrobia Firmicutes Proteobacteria Other phyla (≤ 2%) Enterobacteriaceae Enterococcaceae 
54-C 
Single-dose 
of antibiotic 
cefotaxime 
(C) or 
vancomycin 
(V) 
1.00±0.03 1.00±0.09 1.00±0.13 1.00±0.04 1.00±0.11 1.00±0.31 1.00±0.12 n.d. 
54-M 1.00±0.03 1.00±0.10 1.00±0.21 1.00±0.03 1.00±0.14 1.00±0.25 1.00±0.17 1.00±0.13 
             
54-C.C 1.08±0.08 0.86±0.09 1.20±0.14 1.08±0.02 0.26±0.04* 1.25±0.21 0.12±0.03* n.d. 
54-M.C 1.00±0.09 0.86±0.12 1.26±0.30 1.09±0.04 0.39±0.02* 1.07±0.09 0.14±0.03* 1.04±0.15 
             
54-C.V 1.02±0.10 0.90±0.12 1.28±0.22 1.10±0.01 0.19±0.02* 1.10±0.23 0.06±0.01* n.d. 
54-M.V 0.96±0.04 0.98±0.07 1.14±0.20 1.06±0.04 0.45±0.16 1.01±0.25 0.23±0.17 1.88±0.79 
               
58-C 
Multiple-
dose of 
antibiotic 
cefotaxime 
(C) or 
vancomycin 
(V) 
1.00±0.02 1.00±0.02 1.00±0.14 1.00±0.01 1.00±0.22 1.00±0.12 1.00±0.36 n.d. 
58-M 1.00±0.06 1.00±0.10 1.00±0.11 1.00±0.05 1.00±0.17 1.00±0.22 1.00±0.20 1.00±0.12 
            
58-C.C 0.80±0.07 1.19±0.08 0.73±0.12 1.01±0.00 1.30±0.39 1.52±0.48 1.46±0.47 n.d. 
58-M.C 0.89±0.13 1.19±0.16 0.91±0.23 1.09±0.01 0.18±0.03* 1.27±0.33 0.13±0.03* 0.78±0.05 
            
58-C.V 0.80±0.38 1.16±0.51 0.71±0.32 0.98±0.44 2.76±1.22* 1.07±0.51 3.47±0.85* n.d. 
58-M.V 1.01±0.05 1.02±0.04 0.94±0.17 1.05±0.06 0.68±0.14 0.63±0.15 0.63±0.15 1.18±0.17 
n.d., not detected at T7. 
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*, statistically significant difference (p<0.01) between the FMAs with the addition of antibiotic versus no addition of antibiotic, for each FMA at 
time 7 day 
 
